Insider Action: Expiring Quiet Periods, Lockups, and IPOs for Week of 8/6

Photo of Paul Ausick
By Paul Ausick Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Insider Action: Expiring Quiet Periods, Lockups, and IPOs for Week of 8/6

© Andrew Burton / Getty Images

When company insiders buy or sell stock in their own companies, the transactions may or may not offer a hint about a company’s prospect. Legendary investment manager Peter Lynch once remarked that insiders sell shares for any number of reasons, but they only buy more stock for one reason: they think the price will go up.

There wasn’t a lot of insider buying last week, but there was one transaction worth noting. Salesforce.com chairman and CEO Marc Benioff exercised an option to acquire 20,000 shares at a price of $59.34 per share. The transaction occurred on July 23 and the company’s stock closed that day at $248.25.

In the coming week, seven companies are expected to price initial public offerings (IPOs) and another two are listed as day-to-day. Here’s the full list (the last two are day-to-day). The market cap is based on expected pricing at the midpoint of the IPO price range.

[nativounit]

Company Ticker Price Range Deal Size Market cap
Better Being Co. (BBCO) $15.00 – $17.00 $200 million $843.4 million
Cadre Holdings (CDRE) $16.00 – $19.00 $125 million $606 million
European Wax Center (EWCZ) $15.00 – $18.00 $175 million $1.05 billion
Orange County Bancorp (OBT) $32.00 – $35.00 $30 million $30.2 million
WCG Clinical (WCGC) $14.00 – $16.00 $720 million $6.1 billion
Weber (WEBR) $15.00 – $17.00 $750 million $5.6 billion
Healthcare Royalty (HCRX) $15.00 – $17.00 $750 million $3.45 billion
Context Therapeutics (CNTX) $12.00 – $14.00 $20 million $19.5 million
ROX Financial (ROXA) $10.00 $83 million $89.5 million

After a company submits its first filing for an IPO, company executives typically embark on a “roadshow,” meeting with big investors and brokerages to tout the virtues of both their company and the stock. Once the stock begins trading, however, the company and its staff enter what’s known as a quiet period during which they may not talk about the company or its stock. The quiet period lasts 40 days.

Special-purpose acquisition companies, aka SPACs or blank-check companies, that combine with a start-up to come public in a reverse merger play by different rules. The U.S. Securities and Exchange Commission (SEC) treats these deals as mergers, not IPOs, and often there is no quiet period at all.

Most investment banks that underwrite IPOs do not issue research, including projections, on the company for a period of 25 days. This is done by custom more than by regulation, but the SEC and the courts appear to be satisfied with the length of the underwriters’ quiet period. When these reports are finally made public, they usually reinforce all the reasons the underwriter chose to participate in the IPO in the first place.

A similar restriction applies to company employees (insiders) who may be prohibited from selling any shares they may own for a period of time, generally between 90 and 180 days. For SPACs, the lockup period typically lasts between 180 days and a full year. A lockup period is not mandated by SEC rules, but are set by the company in its IPO registration and is intended to keep insiders from flooding the market with shares and, in so doing, eroding the share price.

For the week ending August 6, nine companies will see their 25-day underwriter research quiet period end and another nine will see the insider lockup periods expire.

Here are the nine companies with lockup expirations coming this week.

Company Ticker Industry
Sana Biotechnology (SANA) Biopharma
Evaxion Biotech A/S (EVAX) Biopharma
Terns Pharmaceuticals (TERN) Biopharma
Immunocore Holdings (IMCR) Biopharma
Bolt Biotherapeutics (BOLT) Biopharma
Lucira Health (LHDX) Medical Devices
Pharvaris B.V. (PHVS) Biopharma
Vor Biopharma (VOR) Biopharma
Angion Biomedia (ANGN) Biopharma

Here are the nine companies for which the underwriter’s quiet period expires this week.

Company Ticker Industry
Moving iMage Technologies (MITQ) Electronics
TransCode Therapeutics (RNAZ) Biopharma
NLS Pharmaceuticals (NLSP) Biopharma
ON24 (ONTF) Enterprise IT
TELUS International (TIXT) Enterprise IT
Landos Biopharma (LABP) Biopharma
Sensei Biotherapeutics (SNSE) Biopharma
Atotech Limited (ATC) Manufacturing
Sentage Holdings (SNTG) Fintech

[recirclink id=923616][wallst_email_signup]

Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for a673b.bigscoots-temp.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618